$55.26
0.16[0.29%]
At close: Apr 26
$55.26
0[0.00%]
After Hours: 4:00PM EDT
Latest News for Enovis Stock (NYSE:ENOV)
Enovis Stock (NYSE: ENOV)
Categories: All
Tuesday, April 16, 2024
Wednesday, April 10, 2024
Friday, February 23, 2024
Thursday, February 22, 2024
- Medtech Firm Enovis Sets Strong 2024 Targets As Q4 Earnings Beat Expectations, Analyst Says Growth IntactVandana Singh - Feb 22, 2024, 1:50PM
- Enovis Forecasts Fiscal Year 2024 Adjusted EPS Of $2.50-$2.65 Versus Consensus Of $2.71Benzinga Newsdesk - Feb 22, 2024, 6:04AM
- Enovis Forecasts Fiscal Year 2024 Revenues Of $2.05B-$2.15B Versus Consensus Of $2.12BBenzinga Newsdesk - Feb 22, 2024, 6:03AM
- Enovis Q4 Adjusted EPS $0.79 Beats $0.74 Estimate, Sales $455.02M Beat $445.36M EstimateBenzinga Newsdesk - Feb 22, 2024, 6:01AM
- Earnings Scheduled For February 22, 2024Benzinga Insights - Feb 22, 2024, 5:27AM
Wednesday, February 21, 2024
Tuesday, February 13, 2024
Monday, January 22, 2024
Monday, January 08, 2024
Wednesday, January 03, 2024
- This Analyst Sees Durable Share Gains, Margin Expansion For Orthopedics-Focused EnovisVandana Singh - Jan 3, 2024, 11:56AM
- William Blair Initiates Coverage On Enovis with Outperform RatingBenzinga Newsdesk - Jan 3, 2024, 10:02AM
- Enovis Completes Acquisition Of LimaCorporate S.p.A To Strengthen Its Position In Global Orthopedic Reconstruction MarketBenzinga Newsdesk - Jan 3, 2024, 6:05AM
Wednesday, December 20, 2023
Friday, December 15, 2023
Wednesday, November 08, 2023
Tuesday, November 07, 2023
- Earnings Scheduled For November 7, 2023Benzinga Insights - Nov 7, 2023, 6:34AM
- Enovis Forecast FY23 Adjusted EPS Of $2.30-$2.40 Compared To Prior Guidance Of $2.22-$2.36 And Consensus of $2.32Benzinga Newsdesk - Nov 7, 2023, 6:12AM
- Enovis Expects FY23 Adjusted EBITDA Of $264M-$270M Compared To Previous Outlook Of $262M-$270MBenzinga Newsdesk - Nov 7, 2023, 6:11AM
- Enovis Expects FY23 Revenue To Organically Grow 7.4-7.6% Y/Y Versus Previous Expectations Of 7-7.5% GrowthBenzinga Newsdesk - Nov 7, 2023, 6:10AM
- Enovis Announces Double-Digit Reconstructive Growth Including +18% In US Hip/Knee In Q3Benzinga Newsdesk - Nov 7, 2023, 6:03AM
- Enovis Q3 Adjusted EPS $0.56 Beats $0.54 Estimate, Sales $417.52M Beat $415.16M EstimateBenzinga Newsdesk - Nov 7, 2023, 6:02AM
Friday, October 20, 2023
- Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023Benzinga Insights - Oct 20, 2023, 11:00AM
- 4 Analysts Have This to Say About EnovisBenzinga Insights - Oct 20, 2023, 8:00AM
- Roth MKM Initiates Coverage On Enovis with Buy Rating, Announces Price Target of $75Benzinga Newsdesk - Oct 20, 2023, 5:46AM
- Needham Reiterates Buy on Enovis, Maintains $70 Price TargetBenzinga Newsdesk - Oct 20, 2023, 4:05AM
Thursday, October 19, 2023
- Why Enovis Stock Is Trading Lower TodayRyan Gustafson - Oct 19, 2023, 3:38PM
- Enovis shares are trading lower after the company announced a proposed private offering of $400 million of convertible senior notes and issued preliminary Q3 results.Benzinga Newsdesk - Oct 19, 2023, 12:53PM
- Enovis Posts Preliminary Results: Sees Q3 Revenues Of $414M-$418M (vs. Cons. $415.16M), Up 8% To 9%, Adjusted EBITDA Of $64M-$66MBenzinga Newsdesk - Oct 19, 2023, 7:07AM
- Enovis Disclosed A Private Offering Of $400M Principal Amount Of Convertible Senior Notes Due 2028Benzinga Newsdesk - Oct 19, 2023, 6:56AM
Monday, September 25, 2023
Monday, September 11, 2023
Friday, August 04, 2023
Thursday, August 03, 2023
- Earnings Scheduled For August 3, 2023Benzinga Insights - Aug 3, 2023, 6:59AM
- Enovis Raises FY23 Outlook: Adj. EPS $2.22 - $2.36 (From $2.18 - $2.32 Prior) Vs. $2.28 Est., Organic Revenue Growth 7% - 7.5% (6% - 7% Prior).Benzinga Newsdesk - Aug 3, 2023, 6:04AM
- Enovis Q2 Adj. EPS $0.61 Beats $0.53 Estimate, Sales $428.50M Beat $419.15M EstimateBenzinga Newsdesk - Aug 3, 2023, 6:01AM
Monday, June 26, 2023
- Enovis Above-Market Growth Potential Surge Would Come from Market Share Gains and Accretive Acquisitions: AnalystVandana Singh - Jun 26, 2023, 2:00PM
- Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023Benzinga Insights - Jun 26, 2023, 11:01AM
- Needham Initiates Coverage On Enovis with Buy Rating, Announces Price Target of $70Benzinga Newsdesk - Jun 26, 2023, 6:05AM